Hiring in the Asia-Pacific pharma industry rise by 2% in Q1 2023
Notably, Management Occupations jobs accounted for a 20% share of the Asia-Pacific pharma industry’s total new job postings in Q1 2023, rise 20% over the prior quarter.
Management Occupations drive pharma hiring activity
Management Occupations, with a share of 20% new job postings, was the occupation with the greatest hiring activity in the Asia-Pacific pharma industry in Q1 2023 , ahead of Life, Physical, and Social Science Occupations with a 14% share of new job postings.
The other prominent roles included Healthcare Practitioners and Technical Occupations with a 7% share in Q1 2023, Computer and Mathematical Occupations with a 6% share and Business and Financial Operations Occupations with a 3% share of new job postings.
Top five companies accounted for 67% of hiring activity
Biocon posted 8,387 jobs in Q1 2023 and registered a growth of 198% over the previous quarter, followed by Novartis with 1,240 jobs and a 78% growth. Takeda Pharmaceutical, with 999 jobs, and Merck, with 983 jobs, recorded a 19% rise and an 18% drop, respectively, while Pfizer recorded a 64% decline with a 859 new job postings during Q1 2023.
Regional analysis of hiring in the Asia-Pacific pharma industry, Q1 2023
India held the leading share of the Asia-Pacific pharma hiring activity with a 62.85% share, a 53% increase over Q4 2022. China was next with 16.53%, four-percentage-point down over the previous quarter.
Source link
#Hiring #AsiaPacific #pharma #industry #rise